These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14766368)

  • 61. Stimulation of delta-opioid receptors reduces the in vivo binding of the cholecystokinin (CCK)-B-selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic systems by endogenous enkephalins.
    Ruiz-Gayo M; Durieux C; Fournié-Zaluski MC; Roques BP
    J Neurochem; 1992 Nov; 59(5):1805-11. PubMed ID: 1357099
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stimulation of either cholecystokinin receptor subtype reduces while antagonists potentiate or sensitize a morphine-induced excitatory response.
    Felicio LF; Mazzini BK; Cacheiro RG; Cruz TN; Flório JC; Nasello AG
    Peptides; 2001 Aug; 22(8):1299-304. PubMed ID: 11457524
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Platelet-activating factor is a potent pyrogen and cryogen, but it does not mediate lipopolysaccharide fever or hypothermia.
    Steiner AA; Romanovsky AA
    Temperature (Austin); 2015; 2(4):535-42. PubMed ID: 27227073
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Involvement of cholecystokinin in peripheral nociceptive sensitization during diabetes in rats as revealed by the formalin response.
    Juárez-Rojop IE; Granados-Soto V; Díaz-Zagoya JC; Flores-Murrieta FJ; Torres-López JE
    Pain; 2006 May; 122(1-2):118-25. PubMed ID: 16527403
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cholecystokinin participates in the mediation of fever.
    Székely M; Szelényi Z; Balaskó M
    Pflugers Arch; 1994 Oct; 428(5-6):671-3. PubMed ID: 7838691
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
    Wunderlich GR; Rotzinger S; Bush DE; DeSousa NJ; Vaccarino FJ
    Brain Res; 2004 Mar; 1001(1-2):95-107. PubMed ID: 14972658
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Peptides of digestive system and brain. Model of the cholecystokinin].
    Gibbs J; Smith GP
    Ann Endocrinol (Paris); 1988; 49(2):113-20. PubMed ID: 3048188
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Receptors for cholecystokinin and gastrin].
    de Weerth A; Bläker M; von Schrenck T
    Z Gastroenterol; 1999 May; 37(5):389-401. PubMed ID: 10413847
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Drozdowicz D; Kwiecień S; Hahn EG
    Regul Pept; 1999 Jun; 82(1-3):19-33. PubMed ID: 10458643
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oestrogen modulates cholecystokinin: opioid interactions in the nervous system.
    Micevych P; Chaban V; Quesada A; Sinchak K
    Pharmacol Toxicol; 2002 Dec; 91(6):387-97. PubMed ID: 12688384
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sickness behavior in fever and hypothermia.
    Szelenyi Z; Szekely M
    Front Biosci; 2004 Sep; 9():2447-56. PubMed ID: 15353297
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Energy Trade-offs in Host Defense: Immunology Meets Physiology.
    Steiner AA; Romanovsky AA
    Trends Endocrinol Metab; 2019 Dec; 30(12):875-878. PubMed ID: 31668960
    [TBL] [Abstract][Full Text] [Related]  

  • 73. INSURMOUNTABLE HEAT: THE EVOLUTION AND PERSISTENCE OF DEFENSIVE HYPERTHERMIA.
    Clint E; Fessler DM
    Q Rev Biol; 2016 Mar; 91(1):25-46. PubMed ID: 27192778
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hyperthermia and the central nervous system.
    Sminia P; Hulshof MC
    Prog Brain Res; 1998; 115():337-50. PubMed ID: 9632942
    [No Abstract]   [Full Text] [Related]  

  • 75. Response.
    Fernandez C; Beeching NJ
    Clin Med (Lond); 2018 Aug; 18(4):351. PubMed ID: 30072568
    [No Abstract]   [Full Text] [Related]  

  • 76. Are the Types of Fever Limited?
    Kennedy H
    Br Med J; 1868 Jan; 1(368):47-8. PubMed ID: 20744985
    [No Abstract]   [Full Text] [Related]  

  • 77. Types of Fever.
    South Med Rec; 1887 Dec; 17(12):521-522. PubMed ID: 36022847
    [No Abstract]   [Full Text] [Related]  

  • 78. Thermoregulation as a disease tolerance defense strategy.
    Schieber AM; Ayres JS
    Pathog Dis; 2016 Dec; 74(9):. PubMed ID: 27815313
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cholecystokinin: possible mediator of fever and hypothermia.
    Szelényi Z; Székely M; Hummel Z; Balaskó M; Romanovsky AA; Pétervári E
    Front Biosci; 2004 Jan; 9():301-8. PubMed ID: 14766368
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cholecystokinin: role in thermoregulation and other aspects of energetics.
    Szelényi Z
    Clin Chim Acta; 2010 Mar; 411(5-6):329-35. PubMed ID: 20036221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.